Back
Pharming Group NV Vs. Abercrombie & Fitch Co. Industry Stock Comparison
Sell
48
PHAR
Pharming Group NV
Last Price:
$17.10
Seasonality Move:
-2.42%
Buy
63
ANF
Abercrombie & Fitch Co.
Last Price:
$129.75
Seasonality Move:
13.5%
Sell
48
Pharming Group NV (PHAR)
is a Sell
Is Pharming Group NV a Buy, Sell or Hold?
-
The current Pharming Group NV [PHAR] share price is $17.80. The Score for PHAR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Abercrombie & Fitch Co. (ANF)
is a Buy
Is Abercrombie & Fitch Co. a Buy, Sell or Hold?
-
The current Abercrombie & Fitch Co. [ANF] share price is $126.84. The Score for ANF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ANF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAR Stock Price Chart
What is Pharming Group NV's stock price today?
-
The Pharming Group NV share price today is $17.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing slight selling pressure.
ANF Stock Price Chart
What is Abercrombie & Fitch Co.'s stock price today?
-
The Abercrombie & Fitch Co. share price today is $126.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANF is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.78 | Buy |
| Relative Strength Index (14 RSI): | 57.12 | Buy |
| Chaikin Money Flow: | -5110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.35 - 17.63) | Buy |
| Bollinger Bands (100): | (13.18 - 16.6) | Buy |
ANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.48 | Buy |
| Relative Strength Index (14 RSI): | 80.9 | Buy |
| Chaikin Money Flow: | 905018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.55 - 121.29) | Buy |
| Bollinger Bands (100): | (72.67 - 104.57) | Buy |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.12 | Buy |
| 20-day SMA: | 17.01 | Buy |
| 50-day SMA: | 15.84 | Buy |
| 200-day SMA: | 12.33 | Buy |
| 8-day EMA: | 14.45 | Buy |
| 20-day EMA: | 8.72 | Buy |
| 50-day EMA: | 4.21 | Buy |
| 200-day EMA: | 1.16 | Buy |
ANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.92 | Buy |
| 20-day SMA: | 110.47 | Buy |
| 50-day SMA: | 87.2 | Buy |
| 200-day SMA: | 84.55 | Buy |
| 8-day EMA: | 121.62 | Buy |
| 20-day EMA: | 110.62 | Buy |
| 50-day EMA: | 96.57 | Buy |
| 200-day EMA: | 93.27 | Buy |
Pharming Group NV Earnings Growth & PHAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.04 per share.
Abercrombie & Fitch Co. Earnings Growth & ANF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $1.44 per share, an increase this year of $4.60 per share, and a decrease next year of $0.90 per share.
Pharming Group NV Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Abercrombie & Fitch Co. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||